Comprehensive Market Analysis on Mice Model Market projected to reach USD 2.5 Billion by 2030 | CAGR of 8.3% | Forecast period 2023-2030, published by MarketDigits

Mice Model Market Scope:
Market size value in 2023 - USD 1.43 Billion
Market size value in 2030 - USD 2.5 Billion
CAGR (2023-2030) - 18.3%
Forecast Period - 2023-2030
Segments Covered - Material Type, Application, End Use and Region
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Shanghai Model Organisms Center, Taconic Biosciences, THE JACKSON LABORATORY, TransCure bioServices, Charles River Laboratories, Cyagen, GemPharmatech.

Download Sample Pages-https://www.marketdigits.com/request/sample/4551

Browse in-depth TOC on Mice Model Market
178-Tables
95-Figures
332-Pages

North America dominates the market for Mice Model.
North America accounts for the largest revenue share in the global Mice Model Market, with a highly developed research infrastructure, including top-tier academic institutions, research hospitals, and pharmaceutical companies. These institutions have strong funding and access to state-of-the-art technologies, making them prime consumers of mice models for various research purposes. Their demand for high-quality, genetically engineered mouse models drives the market growth in North America. The regulatory environment in North America is conducive to biomedical research and innovation. Advanced research infrastructure, a strong biotechnology and pharmaceutical industry, government support, and a favorable regulatory environment positions North America as the dominant market for mice models.
The pharmaceutical industry in Asia Pacific is experiencing exponential growth, driven by factors such as rising healthcare expenditures, a large patient population, and a growing focus on drug development. Governments across Asia Pacific are actively supporting biomedical research through grants, funding programs, and regulatory incentives. Rapid growth in biomedical research, an expanding pharmaceutical industry, technological advancements, government support, outsourcing opportunities, and strategic collaborations has propelled Asia Pacific to the forefront of the mice model market, overshadowing the dominance of other regions.

Ask for Discount- https://www.marketdigits.com/request/discount/4551

Top Key Players Covered in the Report-
Taconic Biosciences, Gubra, Charles River Laboratories, Cyagen, GemPharmatech, genOway, Harbour BioMed, Inotiv, Marshall BioResources, Ozgene Pty Ltd, Shanghai Model Organisms Center, Taconic Biosciences, THE JACKSON LABORATORY, TransCure bioServices and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/4551

Recent Developments-
In October 2022, Taconic Biosciences, a prominent provider of animal models for drug discovery announced the launch of the FcResolv NOG portfolio. This collection represents the initial and singular line of super immunodeficient mice models devoid of residual murine Fc gamma receptors (FcγRs), which are recognized for potentially skewing outcomes in studies focusing on antibody-based therapies.

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-mice-model-market-projected-to-reach-usd-25-billion-by-2030

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.